• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cogent Biosciences, Inc. - Common Stock (NQ:COGT)

36.63 +0.84 (+2.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,951,216
Open 35.81
Bid (Size) 35.40 (100)
Ask (Size) 35.89 (100)
Prev. Close 35.79
Today's Range 35.42 - 37.01
52wk Range 4.550 - 43.73
Shares Outstanding 85,465,249
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cogent Biosciences Inc (NASDAQ:COGT) Shows Bullish Technical Breakout Setup with High Scores ↗
May 02, 2026
Via Chartmill
News headline image
The Great Rotation of 2026: Why Small Caps are Finally Dethroning the Tech Giants
March 27, 2026
The financial landscape of 2026 has been defined by a seismic shift in capital allocation that few analysts predicted with such intensity. For the first time in over a decade, the long-dormant Russell... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy

Performance

YTD
+5.4%
+5.4%
1 Month
+4.0%
+4.0%
3 Month
-3.5%
-3.5%
6 Month
+136.3%
+136.3%
1 Year
+524.0%
+524.0%

More News

Read More
News headline image
The Great Rotation: Small-Caps Seize Market Leadership in Historic 2026 Breakout
March 25, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch ↗
March 21, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding ↗
March 21, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Just Cut a Viridian Stock Position by Over $80 Million. Here's What Investors Should Know ↗
March 21, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know ↗
March 21, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Stock Up 72% Sees $8 Million Sale, but Here's Why One Fund Still Seems Bullish ↗
March 21, 2026
Via The Motley Fool
News headline image
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 ↗
March 20, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain ↗
March 18, 2026
Via The Motley Fool
News headline image
Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet? ↗
March 18, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names ↗
March 18, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Biotech Fund Sold $8 Million of Terns Stock Last Quarter, but Here's Why It Still Seems Very Bullish ↗
March 18, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision ↗
March 13, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug ↗
March 13, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline ↗
March 13, 2026
Via The Motley Fool
News headline image
Biotech Stock Up 365% as This $8 Million Investment Targets a Drug With 3 NDA Filings Planned ↗
March 13, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Small-Cap Renaissance: Russell 2000 Eclipses Big Tech in Historic Early 2026 Surge
March 12, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Energy
News headline image
Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million ↗
February 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough ↗
February 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Large Biotech Fund Sells Shares of Cogent Biosciences for Over $120M ↗
February 01, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Cogent Insider Sells $2.5 Million in Stock Amid Staggering 300% Price Surge ↗
January 11, 2026
Via The Motley Fool
Topics Regulatory Compliance
What's going on in today's after hours session ↗
December 30, 2025
Via Chartmill
News headline image
This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy? ↗
December 09, 2025
Via The Motley Fool
News headline image
Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow? ↗
December 09, 2025
Via The Motley Fool

Frequently Asked Questions

Is Cogent Biosciences, Inc. - Common Stock publicly traded?
Yes, Cogent Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Cogent Biosciences, Inc. - Common Stock trade on?
Cogent Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cogent Biosciences, Inc. - Common Stock?
The ticker symbol for Cogent Biosciences, Inc. - Common Stock is COGT on the Nasdaq Stock Market
What is the current price of Cogent Biosciences, Inc. - Common Stock?
The current price of Cogent Biosciences, Inc. - Common Stock is 36.63
When was Cogent Biosciences, Inc. - Common Stock last traded?
The last trade of Cogent Biosciences, Inc. - Common Stock was at 05/01/26 04:00 PM ET
What is the market capitalization of Cogent Biosciences, Inc. - Common Stock?
The market capitalization of Cogent Biosciences, Inc. - Common Stock is 3.13B
How many shares of Cogent Biosciences, Inc. - Common Stock are outstanding?
Cogent Biosciences, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap